sebox Antibody

What is SEBOX and why is it important in developmental biology research?

SEBOX is a nuclear protein belonging to the Paired homeobox family. In humans, the canonical protein has 190 amino acid residues and a molecular mass of 20.4 kDa . As a suspected transcription factor involved in controlling specification of mesoderm and endoderm during development, SEBOX represents a significant target for developmental biology investigations .

The protein is also known by several synonyms including homeobox OG-9 and skin-, embryo-, brain- and oocyte-specific homeobox . Its subcellular localization in the nucleus is consistent with its putative role as a transcription factor . SEBOX gene orthologs have been identified across multiple species including mouse, rat, bovine, frog, chimpanzee, and chicken, enabling comparative developmental studies .

What are the common applications for SEBOX antibodies in laboratory research?

SEBOX antibodies support multiple experimental applications across developmental biology and molecular research:

The choice of application should align with specific research questions. For instance, IHC and immunofluorescence are particularly valuable for examining SEBOX's nuclear localization in developmental contexts .

What expression patterns of SEBOX should researchers consider when designing experiments?

Mouse SEBOX exhibits highly specific temporal and spatial expression patterns that critically inform experimental design:

This distinctive expression profile suggests SEBOX plays critical roles in maternal-to-zygotic transition during early embryogenesis . Experiments should be timed appropriately to capture these developmental windows, particularly when studying early embryonic processes.

How do researchers validate the specificity of SEBOX antibodies?

Rigorous validation of SEBOX antibodies requires multiple complementary approaches:

• Tissue validation: Testing antibodies on tissues known to express SEBOX (brain, skin, ovary, liver) compared to negative tissues

• Western blot verification: Confirming a single band at the expected molecular weight (~20.4 kDa for human)

• Peptide competition: Pre-incubating antibody with purified SEBOX peptide should abolish specific staining

• Knockout controls: Testing antibodies on samples where SEBOX expression has been genetically eliminated

• Cross-reactivity assessment: Validating antibody performance across relevant experimental species

Multiple commercial vendors validate their SEBOX antibodies through these approaches to ensure specificity before release . Researchers should request validation data when selecting antibodies for their experiments.

What factors should guide selection between different types of SEBOX antibodies?

Selection between polyclonal and monoclonal SEBOX antibodies should be guided by experimental requirements:

For advanced applications like chromatin immunoprecipitation (ChIP), antibodies specifically validated for this purpose should be selected. Commercial SEBOX antibodies are available with reactivity to human, mouse, rat, and zebrafish targets, allowing cross-species research .

How can researchers optimize immunohistochemistry protocols for SEBOX detection?

Optimizing IHC protocols for nuclear proteins like SEBOX requires systematic methodology:

• Sample preparation:

  • Fixation: 10% neutral buffered formalin (24 hours) preserves epitope accessibility

  • Embedding: Standard paraffin processing with controlled temperature to prevent antigen degradation

• Antigen retrieval:

  • Heat-induced epitope retrieval (HIER) using citrate buffer (pH 6.0)

  • Pressure cooking (15 minutes) often superior to microwave methods for nuclear antigens

• Blocking and antibody incubation:

  • 5% normal serum from secondary antibody species (30 minutes)

  • Primary antibody concentration: Titrate from 1:100 to 1:500 for optimal signal-to-noise

  • Incubation: Overnight at 4°C yields most consistent results for nuclear proteins

• Detection system:

  • Polymer-HRP systems provide amplification for potentially low-abundance SEBOX

  • DAB development: 3-5 minutes with careful monitoring to prevent overdevelopment

• Controls:

  • Positive tissue control: Brain or embryonic tissue sections

  • Negative control: Primary antibody omission and isotype controls

This systematic approach enhances detection of nuclear SEBOX protein while minimizing background staining .

What cross-species considerations apply when using SEBOX antibodies?

SEBOX antibodies require careful validation across species due to sequence variations:

When using SEBOX antibodies across species:

• Verify epitope conservation through sequence alignment

• Perform rigorous validation in each species

• Adjust incubation conditions and antibody concentration

• Include appropriate species-specific positive controls

Species differences in fixation sensitivity may necessitate protocol optimization when transitioning between model organisms .

How can SEBOX antibodies be used to study early embryonic development?

SEBOX antibodies provide valuable tools for investigating early developmental processes:

• Immunofluorescence in preimplantation embryos:

  • Whole-mount staining of staged embryos from zygote to blastocyst

  • Co-staining with lineage markers to correlate SEBOX with cell fate

  • Confocal microscopy for precise nuclear localization

• Temporal expression analysis:

  • Serial sampling across developmental stages

  • Correlation with major developmental transitions

  • Quantitative analysis of protein levels during maternal-zygotic transition

• Lineage tracing studies:

  • SEBOX detection in specific blastomeres

  • Correlation with subsequent developmental potential

  • Integration with cell fate markers

• Functional knockdown validation:

  • Verification of SEBOX depletion following RNAi or CRISPR intervention

  • Assessment of developmental consequences

  • Rescue experiments with mutant constructs

These approaches leverage the temporal specificity of SEBOX expression, which is present in maturing oocytes through 2-cell embryos but absent in 4-cell embryos , providing a unique window into early developmental regulation.

What methodological approaches enable investigation of SEBOX's transcriptional regulatory function?

As a putative transcription factor, SEBOX's regulatory functions can be investigated through integrated approaches:

• Chromatin immunoprecipitation (ChIP):

  • Optimize crosslinking conditions for nuclear transcription factors

  • Use validated SEBOX antibodies with confirmed specificity

  • Perform ChIP-seq to identify genome-wide binding profiles

  • Analyze enriched motifs to determine DNA binding preferences

• Transcriptional reporter assays:

  • Clone putative SEBOX-responsive elements upstream of luciferase reporters

  • Co-transfect with SEBOX expression constructs

  • Measure transactivation potential in relevant cell types

  • Perform mutation analysis of binding sites to confirm specificity

• Protein complex identification:

  • Immunoprecipitation with SEBOX antibodies followed by mass spectrometry

  • Identify cofactors and chromatin modifiers that interact with SEBOX

  • Validate interactions through reciprocal co-immunoprecipitation

  • Map interaction domains through deletion constructs

• Functional genomics:

  • Perform RNA-seq following SEBOX knockdown/overexpression

  • Integrate with ChIP-seq data to identify direct targets

  • Analyze enriched pathways relevant to developmental processes

  • Validate key targets through reporter assays and expression analysis

These methodologies provide complementary insights into SEBOX's role as a transcriptional regulator during development, particularly in the context of mesoderm and endoderm specification .

How can modern antibody discovery technologies improve SEBOX antibody development?

Advanced technologies offer promising approaches for next-generation SEBOX antibodies:

• Structural-based antibody design:

  • CryoEM techniques determine antibody-antigen structures at near-atomic resolution

  • Hybrid structural and bioinformatic approaches identify optimal epitopes

  • Structure-guided design enhances specificity for functional domains

• Next-generation sequencing for antibody discovery:

  • High-throughput sequencing of antibody repertoires identifies naturally occurring SEBOX binders

  • Tools like KA-Search enable rapid identification of sequence-similar antibodies

  • Computational analysis predicts binding characteristics and cross-reactivity

• Specialized screening approaches:

  • Phage display with structure-guided selection for high-specificity binders

  • Single B-cell approaches to isolate naturally occurring antibodies

  • Advanced screening cascades with multiple specificity filters

• Recombinant antibody engineering:

  • Generation of recombinant fragments with improved tissue penetration

  • Humanization for potential therapeutic applications

  • Site-specific conjugation for advanced imaging applications

These technologies can significantly enhance SEBOX antibody quality, enabling more precise and sensitive detection across experimental applications .

What advanced techniques can be combined with SEBOX immunodetection for functional studies?

Integrating SEBOX antibodies with cutting-edge techniques enhances functional insights:

• Proximity ligation assay (PLA):

  • Detect protein-protein interactions involving SEBOX in situ

  • Visualize interactions with potential cofactors at endogenous expression levels

  • Map interaction networks in different developmental contexts

• CUT&RUN or CUT&Tag:

  • Use SEBOX antibodies for high-resolution chromatin profiling

  • Achieve greater sensitivity than traditional ChIP approaches

  • Generate genome-wide binding maps from limited sample material

• Mass spectrometry with immunoprecipitation:

  • Identify post-translational modifications of SEBOX

  • Characterize the complete SEBOX interactome

  • Compare modification states between different developmental stages

• Single-cell approaches:

  • Combine immunofluorescence with single-cell transcriptomics

  • Correlate SEBOX protein levels with cell-specific gene expression

  • Map heterogeneity in SEBOX activity across developmental populations

• Super-resolution microscopy:

  • Resolve subnuclear localization with nanometer precision

  • Track dynamic redistribution during developmental processes

  • Co-localize with chromatin features and transcriptional machinery

These integrated approaches leverage antibody specificity while providing deeper functional insights than conventional detection methods alone .

How can SEBOX antibodies be used to investigate mesoderm and endoderm specification?

Investigating SEBOX's role in germ layer specification requires sophisticated experimental designs:

• Lineage tracing with multiplexed immunohistochemistry:

  • Combine SEBOX antibodies with markers for mesoderm (Brachyury/T) and endoderm (Sox17, Foxa2)

  • Perform sequential staining to analyze co-expression patterns

  • Apply computational image analysis to quantify co-localization

• In vitro differentiation models:

  • Monitor SEBOX expression during directed differentiation protocols

  • Correlate with emergence of germ layer markers

  • Perform gain/loss-of-function studies with temporal control

• ChIP-seq in developmental contexts:

  • Map SEBOX binding sites during mesoderm/endoderm induction

  • Identify direct target genes involved in specification

  • Integrate with histone modification data to assess enhancer activity

• Genome editing combined with antibody detection:

  • Generate domain-specific SEBOX mutations

  • Validate mutant protein expression with antibodies

  • Assess impact on downstream lineage specification events

• Organoid models:

  • Track SEBOX expression during organoid development

  • Correlate with emergence of tissue-specific structures

  • Perform comparative analysis across different organoid types

These approaches provide complementary insights into SEBOX's suspected role in controlling specification of mesoderm and endoderm during development , potentially revealing mechanisms underlying early lineage decisions.